Prof. Dr. med. Peter Fasching

Professur für Translationale Frauenheilkunde und Geburtshilfe

DIFFERENT NUTRIENT INTAKE AND PREVALENCE OF GASTROINTESTINAL COMORBIDITIES IN WOMEN WITH ENDOMETRIOSIS (2019) Schink M, Konturek PC, Herbert SL, Renner SP, Burghaus S, Blum S, Fasching P, et al. Journal article Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer (2019) Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fießler C, Hein A, et al. Journal article Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study (2019) Deniz M, Degregorio A, Degregorio N, Bekes I, Widschwendter P, Schochter F, Ernst K, et al. Journal article Genome-wide association study of germline variants and breast cancer-specific mortality (2019) Escala-Garcia M, Guo Q, Doerk T, Canisius S, Keeman R, Dennis J, Beesley J, et al. Journal article Update Breast Cancer 2019 Part 2-Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice (2019) Janni W, Schneeweiss A, Mueller V, Woeckel A, Lux MP, Hartkopf AD, Nabieva N, et al. Journal article, Review article Update Breast Cancer 2019 Part 1-Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer (2019) Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Nabieva N, Taran FA, et al. Journal article, Review article The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer (2019) Banys-Paluchowski M, Witzel I, Aktas B, Fasching P, Hartkopf A, Janni W, Kasimir-Bauer S, et al. Journal article Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial (2019) Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marme F, Schneeweiss A, Mundhenke C, et al. Journal article Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (2019) Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, et al. Journal article Translational highlights in breast cancer research and treatment: recent developments with clinical impact (2019) Fasching P, Schneeweiss A, Kolberg HC, Ettl J, Fehm TN, Overkamp F, Lueftner D Journal article, Review article